ストックスクリーナーアプリを入手
9.10
1.79%
0.16
アフターアワーズ：
9.10
前日終値:
$8.94
開ける：
$9.1
24時間の取引高:
3,815
Relative Volume:
0.54
時価総額：
$617.30M
収益：
$277.56M
当期純損益:
$-13.33M
株価収益率:
-35.00
EPS:
-0.26
ネットキャッシュフロー:
$-6.54M
1週間 パフォーマンス:
+1.31%
1か月 パフォーマンス:
+18.49%
6か月 パフォーマンス:
+11.52%
1年 パフォーマンス:
-18.79%
1日の値動き範囲:
$9.05
$9.27
1週間の範囲:
$8.24
$9.27
52週間の値動き範囲:
$6.65
$13.20
Pharming Group N V Adr Stock (PHAR) Company Profile
PHAR を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
PHAR
Pharming Group N V Adr
|
9.10 | 617.30M | 277.56M | -13.33M | -6.54M | -0.19 |
|
VRTX
Vertex Pharmaceuticals Inc
|
397.27 | 102.31B | 10.63B | -479.80M | -1.35B | -1.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
701.85 | 77.13B | 13.85B | 4.65B | 3.32B | 40.41 |
|
ARGX
Argen X Se Adr
|
623.82 | 37.30B | 1.86B | -40.29M | -1.28B | -0.85 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
245.44 | 31.66B | 2.09B | -332.26M | 16.06M | -2.62 |
|
BNTX
Biontech Se Adr
|
113.08 | 27.11B | 3.30B | -501.07M | 1.03B | -2.1146 |
Pharming Group N V Adr Stock (PHAR) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2024-12-09 | 開始されました | Jefferies | Buy |
Pharming Group N V Adr (PHAR) 最新ニュース
Pharming Group stock gains on KL1333’s blockbuster potential, says RBC - Investing.com India
Pharming announces public cash offer to the shareholders of Abliva AB - GlobeNewswire Inc.
H.C. Wainwright reiterates Buy on Pharming stock, pediatric trial shows safety and tolerability - Investing.com
Jefferies initiates Pharming Group shares with Buy on revenue growth - Investing.com India
Oppenheimer cuts Pharming Group stock target, Outperform on Q3 results - Investing.com India
Earnings call: Pharming Group NV reports growth amid CEO transition - Investing.com
Earnings call: Pharming Group NV sees robust growth in Q3, CEO to step down - Investing.com
October 2024's Promising Penny Stocks to Watch - Yahoo Finance
Novavax (NVAX) Moves 19.2% Higher: Will This Strength Last? - Yahoo Finance
Earnings call: Pharming Group reports robust growth and pipeline expansion - Investing.com India
Pharming Group stock hits 52-week low at $6.9 amid challenges - Investing.com
Bath & Body Works, Designer Brands And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session - Benzinga
Pharming Group (PHAR) Surges 7.2%: Is This an Indication of Further Gains? - Yahoo Finance
Pharming (PHAR) Rare Disease Drug Joenja Gets FDA Nod, Stock Up - Nasdaq
Can Pharming Group N.V. Sponsored ADR (PHAR) Run Higher on Rising Earnings Estimates? - Zacks Investment Research
PHARM Stock Price and Chart — EURONEXT:PHARM - TradingView
Pharming Group N V Adr (PHAR) 財務データ
収益
当期純利益
現金流量
EPS
2.88%
2.65%
大文字化:
|
ボリューム (24 時間):